[Treatment by corticosteroid and plasma exchange in 5 cases of renal cholesterol embolic disease]
Related Experiment Video
Updated: Aug 1, 2026

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
Published on: November 7, 2017
M Hasegawa1, S Kawashima, M Shikano
1Department of Nephrology, Fujita Health University School of Medicine, Aichi, Japan.
Abstract:
Cholesterol arterial embolization is a systemic disease resulting from cholesterol crystal embolization to multiple organs, including the kidney, skin, brain, eye, gastrointestinal tract and extremities. In general, it is associated with high morbidity and mortality, but no optimal treatment has yet been developed. In this paper, we report five patients with cholesterol atheroembolic renal failure. In three of the five patients, combined therapy with corticosteroids and plasma exchange was performed. The three patients survived. On the other hand, the two remaining patients died of multifactorial causes. In this report, the literature on steroid therapy for cholesterol atheroembolic renal disease is reviewed and the efficacy of combined therapy by use of corticosteroids and plasma exchange is evaluated.
Related Concept Videos
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Peripheral Artery Disease III: Interprofessional Care
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Nephrotic Syndrome II : Assessment and Medical Management
Kidney Transplant II: Surgical Procedure
Acute Kidney Injury V: Interprofessional Care

